A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
Clinical trial NCT00745823 · TERMINATED
Trial details
- NCT number
- NCT00745823
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 775
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.